Why identity is the first gate
A peptide COA can show a high purity number and still fail the most basic question if the major peak is not the intended sequence. Identity testing is the gate that turns a peak into a named molecule. Without it, purity is only a statement about how dominant one signal is under one method.
Reviewed COA examples describe identity with UV/Vis lambda-max language. That can be useful for molecules with a characteristic absorbance profile, but it is not sequence-specific. Many organic molecules can absorb in similar UV regions, and a UV maximum does not directly measure molecular weight, charge state, adducts, truncations, or sequence-related substitutions.
How LC-MS builds stronger evidence
LC-MS couples a separation step with a mass analyzer. The liquid chromatography portion moves the dissolved sample through a column so the main peptide and related impurities can elute at different times. As each component exits the column, the mass spectrometer ionizes it, sorts ions by mass-to-charge ratio, and records a spectrum.
For peptide identity, the intact molecular ion is the first anchor. The expected molecular weight is calculated from the amino-acid sequence and any known terminal modifications, salts, labels, or protecting-group state. The observed mass should fall inside a defined tolerance for the instrument and method. High-resolution MS tightens that tolerance and helps distinguish nearby formulas.
When intact mass is not enough, MS/MS fragmentation can provide sequence evidence. The peptide ion is fragmented into smaller ions; the pattern of fragment masses can support the amino-acid order and reveal where substitutions, oxidations, deamidations, or truncations may sit.
What a useful identity COA should show
A strong identity section should not only say match. It should show the analytical method, expected mass, observed mass or mass error, chromatographic retention context, and whether identity was assigned from intact mass alone or from MS/MS confirmation.
For a research peptide, the most important distinction is between evidence of the intended molecule and evidence of the amount of material. LC-MS identity answers the first question. Quantitative assay answers the second.
- Expected monoisotopic or average mass, depending on method.
- Observed mass or mass-to-charge peaks and charge-state interpretation.
- Mass tolerance or acceptance rule used by the lab.
- Whether MS/MS fragmentation was acquired for sequence support.
- Any major unexplained co-eluting or nearby mass signals.
Where UV/Vis identity fits
UV/Vis identity can still be a useful orthogonal screen. If a molecule has a stable absorbance feature and the sample preparation is controlled, a lambda-max comparison can flag a mismatch or gross substitution. The limitation is specificity: UV absorbance is not a molecular fingerprint in the same way mass and fragmentation are.
A practical upgrade path is not to discard the UV/Vis row, but to stop making it carry the whole identity claim. Use UV/Vis as a supporting observation and LC-MS as the molecular identity anchor.
- A mass match supports identity only within the specificity of the method. It does not prove purity, potency, sterility, or suitability for any use.
- A single clean mass spectrum is stronger when paired with retention time, system suitability, and a reference standard or validated library match.
- If a COA reports only lambda max, the identity claim is narrower than a sequence-anchored LC-MS assignment.
- Isobaric or near-isobaric substitutions may require MS/MS or orthogonal chemistry to distinguish.
- Salts, adducts, counterions, and sample-preparation conditions can complicate mass interpretation.
- LC-MS identity does not quantify the net peptide content in the vial unless paired with a validated assay.
Accuracy checks before relying on this result.
- Do not treat a mass match as complete sequence proof when isobaric residues, substitutions, adducts, or modifications could explain the same signal.
- Do not let an identity result imply purity, fill amount, sterility, endotoxin status, stability, or suitability for any use.
- Require chromatographic context so the reported mass is tied to the main component, not an unrelated or co-eluting signal.
What a stronger report should make visible.
- Method named as LC-MS, HRMS, or LC-MS/MS rather than only qualitative ID.
- Expected and observed mass reported with acceptance criteria.
- Chromatographic context included so the mass belongs to the main peak.
- Clear handling of adducts, charge states, modifications, and unresolved peaks.
Analytical scope
This article is educational content about analytical chemistry and COA interpretation. It does not state that any peptide is safe, effective, sterile, injectable, therapeutic, approved, compliant, or fit for human or animal use.
Educational use, no reliance, and liability limits.
These pages are general analytical education only. They are not medical, safety, legal, regulatory, quality-system, purchasing, or product-use advice, and they do not state that any material is safe, effective, sterile, injectable, therapeutic, approved, compliant, or fit for human or animal use.
- Official standards, signed lab records, applicable law, and qualified professional review control.
- Visitors use and rely on this content at their own risk.
- To the fullest extent permitted by law, Purity Analytics LLC disclaims warranties and liability for losses arising from access, use, or reliance.
Scientific anchors
These references are used as method-development and interpretation anchors. They do not turn this page into a regulated product release protocol.
